All Stories

  1. Air sampling to assess potential generation of aerosolized viable bacteria during flow cytometric analysis of unfixed bacterial suspensions
  2. Human pleural fluid is a potent growth medium for Streptococcus pneumoniae
  3. Analysis of early mesothelial cell responses to Staphylococcus epidermidis isolated from patients with peritoneal dialysis-associated peritonitis
  4. In vitrodata support the investigation of vinegar as an antimicrobial agent for PD-associatedPseudomonasexit site infections
  5. Therapeutic Potential of Tea Tree Oil for Scabies
  6. Effects of a Statewide Protocol for the Management of Peritoneal Dialysis-Related Peritonitis on Microbial Profiles and Antimicrobial Susceptibilities: A Retrospective Five-Year Review
  7. Scabies: an ancient global disease with a need for new therapies
  8. Lack of evidence that essential oils affect puberty
  9. Effect of habituation to tea tree (Melaleuca alternifolia) oil on the subsequent susceptibility of Staphylococcus spp. to antimicrobials, triclosan, tea tree oil, terpinen-4-ol and carvacrol
  10. Candida albicans adhesion to human epithelial cells and polystyrene and formation of biofilm is reduced by sub-inhibitory Melaleuca alternifolia (tea tree) essential oil
  11. Inhibition of ruminal bacteria involved in lactic acid metabolism by extracts from Australian plants
  12. Effects of Melaleuca alternifolia (Tea Tree) Essential Oil and the Major Monoterpene Component Terpinen-4-ol on the Development of Single- and Multistep Antibiotic Resistance and Antimicrobial Susceptibility
  13. Survey of the Antimicrobial Activity of Commercially Available Australian Tea Tree ( Melaleuca alternifolia ) Essential Oil Products In Vitro
  14. Uncontrolled, open-label, pilot study of tea tree (Melaleuca alternifolia) oil solution in the decolonisation of methicillin-resistant Staphylococcus aureus positive wounds and its influence on wound healing
  15. Antibacterial and Antifungal Activities of Essential Oils
  16. Chemistry and Bioactivity of Essential Oils
  17. Inhibition of established subcutaneous murine tumour growth with topical Melaleuca alternifolia (tea tree) oil
  18. Induction of necrosis and cell cycle arrest in murine cancer cell lines by Melaleuca alternifolia (tea tree) oil and terpinen-4-ol
  19. Antimicrobial and anti-inflammatory activity of fiveTaxandria fragransoilsin vitro
  20. Diagnosis of Helicobacter pylori Infection in a High-prevalence Pediatric Population: A Comparison of 2 Fecal Antigen Testing Methods and Serology
  21. Frequencies of resistance to Melaleuca alternifolia (tea tree) oil and rifampicin in Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis
  22. Role of the MexAB-OprM Efflux Pump of Pseudomonas aeruginosa in Tolerance to Tea Tree (Melaleuca alternifolia) Oil and Its Monoterpene Components Terpinen-4-ol, 1,8-Cineole, and α-Terpineol
  23. Use of deception to achieve double-blinding in a clinical trial of Melaleuca alternifolia (tea tree) oil for the treatment of recurrent herpes labialis
  24. Susceptibility of pseudomonads to Melaleuca alternifolia (tea tree) oil and components
  25. A review of the toxicity of Melaleuca alternifolia (tea tree) oil
  26. Melaleuca alternifolia (Tea Tree) Oil: a Review of Antimicrobial and Other Medicinal Properties
  27. Effectiveness of hand-cleansing formulations containing tea tree oil assessed ex vivo on human skin and in vivo with volunteers using European standard EN 1499
  28. Assessment of the antibacterial activity of tea tree oil using the European EN 1276 and EN 12054 standard suspension tests
  29. Tolerance of Pseudomonas aeruginosa to Melaleuca alternifolia (tea tree) oil is associated with the outer membrane and energy-dependent cellular processes
  30. Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae
  31. Susceptibility of oral bacteria to Melaleuca alternifolia (tea tree) oil in vitro
  32. Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil
  33. In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi
  34. Mechanism of Action of Melaleuca alternifolia (Tea Tree) Oil on Staphylococcus aureus Determined by Time-Kill, Lysis, Leakage, and Salt Tolerance Assays and Electron Microscopy
  35. Melaleuca alternifolia (tea tree) oil gel (6%) for the treatment of recurrent herpes labialis
  36. Safety, efficacy and provenance of tea tree (Melaleuca alternifolia) oil
  37. Tea tree oil as an alternative topical decolonization agent for methicillin-resistant Staphylococcus aureus
  38. The water-soluble components of the essential oil of Melaleuca alternifolia (tea tree oil) suppress the production of superoxide by human monocytes, but not neutrophils, activated in vitro
  39. Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes
  40. Tea tree oil as an alternative topical decolonization agent for methicillin-resistant Staphylococcus aureus
  41. Melaleuca alternifolia (tea tree) oil inhibits germ tube formation by Candida albicans
  42. Prevalence of delayed hypersensitivity to the European standard series in a self-selected population
  43. In Vitro Activities of Ketoconazole, Econazole, Miconazole, and Melaleuca alternifolia (Tea Tree) Oil against Malassezia Species
  44. Allergic contact dermatitis following use of a tea tree oil hand-wash not due to tea tree oil
  45. Antimicrobial activity of essential oils and other plant extracts
  46. Influence of organic matter, cations and surfactants on the antimicrobial activity of Melaleuca alternifolia (tea tree) oil in vitro
  47. In-vitro activity of essential oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp
  48. Efficacy and safety of tea tree oil as a topical antimicrobial agent
  49. In vitrosusceptibility ofMalassezia furfurto the essential oil ofMelaleuca alternifolia
  50. Susceptibility of transient and commensal skin flora to the essential oil of Melaleuca alternifolia (tea tree oil)
  51. In-vitro activity of the essential oil of Melaleuca alternifolia against Streptococcus spp
  52. Antimicrobial activity of the major components of the essential oil ofMelaleuca alternifolia
  53. Susceptibility of methicillin-resistant Staphylococcus aureus to the essential oil of Melaleuca alternifolia
  54. Toxicity of the Essential Oil ofMelaleuca alternifoliaor Tea Tree Oil
  55. Susceptibility of Propionibacterium acnes to the essential oil of Melaleuca alternifolia
  56. Antimicrobial activity of the essential oil of Melaleuca alternifolia
  57. Ciprofloxacin and Clostridium difficile -associated diarrhoea
  58. Ciprofloxacin and Clostridium difficile-associated diarrhoea
  59. Ciprofloxacin and pseudomembranous colitis